[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.175.236. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News and Perspectives
October 17, 2007

Scientists Examine Benefits, Risks of Treating Preschoolers With ADHD Drugs

JAMA. 2007;298(15):1747-1749. doi:10.1001/jama.298.15.1747

The use of methylphenidate and other psychotropic drugs to treat preschool-aged children with attention-deficit/hyperactivity disorder (ADHD) has long been controversial because few data previously had been available to support the practice. Now a growing body of preliminary evidence indicates that these very young children can benefit from such treatment but that adverse events in this age group require special consideration.

Other studies are probing the potential long-term consequences of treatment and exploring the role of genetics in the disorder.

First Page Preview View Large
First page PDF preview
First page PDF preview
×